U.S. prices for brand-name drugs are rising faster than ever as patents expire on top-selling medicines and the pharmaceutical industry nervously eyes the future of health care reform.
Disclaimer: All trademarks used on this site and brand names are the property of the respective trademark holders. We are not associated with these trademark holder companies in any sense and have never been affiliated with them.